Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding
98,762,388
Total 13F shares
737,001
Share change
-333,000
Total reported value
$7,745,886
Price per share
$10.51
Number of holders
3
Value change
-$4,367,115
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Knoll Capital Management, LLC
13F
Company
0.61%
600,000
 $7,869,000 — 30 Sep 2024
13F
David M. Knott Jr.
13F
Individual
0.34%
332,000
 $4,354,000 — 30 Sep 2024
13F
SCHULHOFF & CO INC
13F
Company
0.14%
137,000
 $1,796,755 — 30 Sep 2024
13F
1620 INVESTMENT ADVISORS, INC.
13F
Company
0%
1,000
 $13,115 — 30 Sep 2024
13F
HUNTINGTON NATIONAL BANK
13F
Company
0%
1
 $16 — 30 Sep 2024
13F
Douglas J. Williamson
3/4/5
Chief Medical Officer —
class O/S missing
275,000
 — — 14 Feb 2022
3/4/5
Richard J. Kim
3/4/5
Chief Commercial Officer —
class O/S missing
147,000
 — — 20 Feb 2024
3/4/5

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q4 2024

As of 31 Dec 2024, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 737,001 shares. The largest 3 holders included Knoll Capital Management, LLC, SCHULHOFF & CO INC, and HUNTINGTON NATIONAL BANK. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
5
Q4 2024 holders
3
Holder diff
-2
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .